The JSE was firmer on Wednesday along with European markets, as investors shrug off concerns over tech stocks losses and a Covid-19 vaccine candidate.

European shares shrugged off heavy losses for US tech stocks on Wednesday, while major drugmaker AstraZeneca delayed testing of a possible coronavirus vaccine, Reuters reported.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now